# A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

> **NCT01197001** · PHASE1 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 72 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Amlodipine plus Losartan
- **DRUG:** Amlodipine, Losartan

## Key facts

- **NCT ID:** NCT01197001
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2010-10
- **Final completion:** 2010-11
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2011-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01197001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01197001, "A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01197001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*